Covered recipient · General Payments record
TERRY DESHAWN CRUMBLEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,278.76
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.06 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $127.25 | 7 |
| PFIZER INC. | $98.13 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.05 | 1 |
| Abbott Laboratories | $27.74 | 1 |
| E.R. Squibb & Sons, L.L.C. | $25.97 | 1 |
| CHIESI USA, INC. | $22.79 | 1 |
| Acerta Pharma LLC | $21.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.15 | 1 |
| Amgen Inc. | $16.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.74 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124960263 | CMS |
| Amgen Inc. | $16.12 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231397 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.86 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105462150 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.05 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117949921 | CMS |
| Chiesi USA, Inc. | $22.79 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151828936 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.97 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101775561 | CMS |
| Novartis Pharmaceuticals Corporation | $20.15 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086718715 | CMS |
| Novo Nordisk Inc | $22.45 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437151 | CMS |
| Novo Nordisk Inc | $19.12 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100472255 | CMS |
| Novo Nordisk Inc | $15.54 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100460462 | CMS |
| Novo Nordisk Inc | $18.65 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100542632 | CMS |
| Novo Nordisk Inc | $16.30 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100565264 | CMS |
| Novo Nordisk Inc | $15.37 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100588501 | CMS |
| Novo Nordisk Inc | $19.82 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818126 | CMS |
| PFIZER INC. | $21.34 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130978787 | CMS |
| PFIZER INC. | $31.41 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131384413 | CMS |
| PFIZER INC. | $22.53 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131477706 | CMS |
| PFIZER INC. | $22.85 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131750988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.